Association of Asymmetric Dimethylarginine and Diastolic Dysfunction in Patients with Hypertrophic Cardiomyopathy
Open Access
- 13 July 2019
- journal article
- research article
- Published by MDPI AG in Biomolecules
- Vol. 9 (7), 277
- https://doi.org/10.3390/biom9070277
Abstract
Despite genetic heterogeneity, early manifestation of diastolic dysfunction (DD) is common in hypertrophic cardiomyopathy (HCM). Nitric oxide (NO) may contribute to myocardial relaxation. NO synthases (NOS) use l-arginine (Arg) as a substrate, as asymmetric dimethylarginine (ADMA) is a direct endogenous inhibitor of NOS. This study aimed to analyze the association of Arg and its derivates, i.e., l-homoarginine (hArg), ADMA and symmetric dimethylarginine (SDMA), with DD in HCM patients. In 215 HCM patients (mean age 54 ± 15 years, 58% male) transmitral and mitral annulus velocities were echocardiographically analyzed. Plasma concentrations of Arg derivatives were measured by liquid chromatography tandem-mass spectrometry. In 143 (70%) patients suffering from DD, ADMA showed the strongest association with DD (0.66 ± 0.16, 0.72 ± 0.24, and 0.76 ± 0.26 µmol/L, p < 0.01 for trend). In linear regression analyses, positive association per standard deviation increase of ADMA was found with E-wave (beta coefficient (95% confidence interval): 4.72 (0.43–9.01); p < 0.05) and mean E/E’ (1.76 (0.73–2.79) p < 0.001). Associations were adjusted for age, sex, body mass index (BMI), diabetes mellitus, coronary artery disease, and arterial hypertension. Elevated ADMA is associated with the severity of DD in HCM. Higher ADMA level might lead to decreased NO production and thus an impaired myocardial relaxation pattern.This publication has 35 references indexed in Scilit:
- Asymmetric and Symmetric Dimethylarginine Predict Outcomes in Patients With Atrial FibrillationJournal of the American College of Cardiology, 2018
- Myocardial contraction fraction derived from cardiovascular magnetic resonance cine images—reference values and performance in patients with heart failure and left ventricular hypertrophyEuropean Heart Journal – Cardiovascular Imaging, 2017
- Effect of asymmetric dimethylarginine (ADMA) on heart failure developmentNitric Oxide, 2016
- Elevated Levels of Asymmetric Dimethylarginine (ADMA) in the Pericardial Fluid of Cardiac Patients Correlate with Cardiac HypertrophyPLOS ONE, 2015
- L-Homoarginine and cardiovascular diseaseCurrent Opinion in Clinical Nutrition and Metabolic Care, 2015
- Stable isotope dilution assay for liquid chromatography–tandem mass spectrometric determination of l-homoarginine in human plasmaJournal of Chromatography B, 2011
- Paracrine and autocrine effects of nitric oxide on myocardial functionPharmacology & Therapeutics, 2000
- Interference ofL-Arginine Analogues withL-Arginine Transport Mediated by the y+Carrier hCAT-2BNitric Oxide, 1997
- Modulation of left ventricular relaxation in isolated ejecting heart by endogenous nitric oxideAmerican Journal of Physiology-Heart and Circulatory Physiology, 1994
- NITRIC OXIDE: A Physiologic Messenger MoleculeAnnual Review of Biochemistry, 1994